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ABSTRACT
Viperin is a multifunctional protein that was first identified in human primary macrophages 
treated with interferon-γ and in human fibroblasts infected with human cytomegalovirus. 
This protein plays a role as an anti-viral protein and a regulator of cell signaling pathways 
or cellular metabolism when induced in a variety of cells such as fibroblasts, hepatocytes 
and immune cells including T cells and dendritic cells. However, the role of viperin in 
macrophages is unknown. Here, we show that viperin is basally expressed in murine 
bone marrow cells including monocytes. Its expression is maintained in bone marrow 
monocyte-derived macrophages (BMDMs) depending on macrophage colony-stimulating 
factor (M-CSF) treatment but not on granulocyte-macrophage colony-stimulating factor 
(GM-CSF) treatment. In wild type (WT) and viperin knockout (KO) BMDMs differentiated 
with M-CSF or G-MCSF, there are little differences at the gene expression levels of M1 and 
M2 macrophage markers such as inducible nitric oxide synthase (iNOS) and arginase-1, and 
cytokines such as IL-6 and IL-10, indicating that viperin expression in BMDMs does not affect 
the basal gene expression of macrophage markers and cytokines. However, when BMDMs 
are completely polarized, the levels of expression of macrophage markers and secretion 
of cytokines in viperin KO M1 and M2 macrophages are significantly higher than those in 
WT M1 and M2 macrophages. The data suggest that viperin plays a role as a regulator in 
polarization of macrophages and secretion of M1 and M2 cytokines.
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INTRODUCTION
Macrophages play a critical role in antigen presentation, phagocytosis, and 
immunomodulation (1). They can be polarized into classically activated macrophages (M1) 
or alternatively activated macrophages (M2) in response to different stimulation (2). M1 
and M2 macrophages have different roles in inflammation. M1 macrophages are associated 
with production of pro-inflammatory cytokines such as tumor necrosis factor (TNF)-α, 
IL-6, and IL-12 and provide a host defense against infections, while M2 macrophages secrete 
anti-inflammatory cytokines such as transforming growth factor (TGF)-β and IL-10 and 
have reparative function (3,4). M1 macrophages stimulated by interferon (IFN)-γ and/or 
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lipopolysaccharides (LPS) or microbial product express high levels of CD68 marker, CD80 
and CD86 costimulatory molecules, major histocompatibility complex (MHC) class II, 
and inducible nitric oxide synthase (iNOS) (3,4). M2 macrophages induced by IL-4 or IL-13 
express increased levels of arginase-1 (Arg-1), CD206 mannose receptor, and CD163 marker 
(3,4). Moreover, recent studies showed that M1 and M2 macrophages can be converted into 
each other in their specific microenvironment (5-7).
Viperin (virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) 
was first identified as a gene induced by IFN-γ in human primary macrophages and by human 
cytomegalovirus infection in human fibroblasts (8,9). It is also induced in a variety of cells by 
type I, II, and III IFNs, double-stranded (ds) B-form DNA, the dsRNA analog polyinosinic-
polycytidylic acid, LPS, and many other viral infections (10). Viperin is a multifunctional 
protein. It functions as an anti-viral protein against many viruses in the majority of cell types 
including fibroblasts, hepatocytes, and astrocytes (8,11-14). This protein also plays a role as 
a regulator of cell signaling pathways in plasmacytoid dendritic cells and T helper 2 cells 
(15,16). Moreover, it functions as a pro-viral protein by modulating cellular energy and lipid 
metabolism in fibroblasts infected with human cytomegalovirus (17,18). Although viperin's 
functions in a variety of cell types were well known, the role of viperin in macrophages in 
which it was identified remains to be elucidated.
In this study, we showed that viperin is expressed in murine bone marrow cells including 
monocytes, and its expression is kept in bone marrow-derived macrophages (BMDMs) 
differentiated with macrophage colony-stimulating factor (M-CSF). Using BMDMs prepared 
from viperin knockout (KO) mice, we found that viperin deficiency facilitates polarization of 
BMDMs into M1 and M2 macrophages and secretion of cytokines, suggesting that viperin has 
a pivotal role as a regulator in macrophage polarization.
MATERIALS AND METHODS
Cells, antibodies, and reagents
Murine bone marrow cells used in the study were isolated from wild type (WT) or viperin 
(also known as Rsad2) KO C57BL/6 mice (18).
Viperin was detected with the monoclonal mouse antibody to viperin (MaP.VIP) described 
previously (8,13). The monoclonal mouse anti-β-actin antibody (Sigma-Aldrich, St. Louis, 
MO, USA), horseradish peroxidase-conjugated goat anti-rabbit or anti-mouse IgG antibody 
(Jackson ImmunoResearch Laboratories, West Grove, PA, USA), PE-conjugated anti-Ly-6C or 
anti-F4/80 antibody (BioLegend, San Diego, CA, USA), and PerCP-Cy5.5-conjugated anti-
CD11b antibody (BD Biosciences, Franklin Lakes, NJ, USA) were used.
Mouse M-CSF or granulocyte macrophage colony-stimulating factor (GM-CSF) is stably 
expressed in CHO cells as described previously (19). The culture supernatants containing the 
secreted M-CSF or GM-CSF were used for generation of BMDMs.
Polarization of M1 and M2 macrophages
To generate BMDMs, the bone marrow cells from femurs and tibias of mice were harvested 
and cultured in RPMI (Hyclone™; GE Healthcare, Chicago, IL, USA) supplemented with 
10% fetal bovine serum (FBS) (Hyclone™; GE Healthcare), 1% penicillin/streptomycin 
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(Sigma-Aldrich), and 10% M-CSF or GM-CSF supernatants for 7 days. BMDMs cultured in 
M-CSF conditioned media were washed and plated at a density of 5–6 × 106 cells/well in 6-well 
plate (SPL Life Sciences, Pocheon, Korea) containing RPMI media without M-CSF. For M1 
polarization, cells were classically activated with 100 ng/ml LPS (Sigma-Aldrich) + 20 ng/
ml IFN-γ (R&D Systems, Minneapolis, MN, USA) for 24 h. For M2 polarization, cells were 
alternatively activated with 20 ng/ml IL-4 (PrimeGene, Shanghai, China) for 48 h.
Flow cytometry
BMDMs, M1 or M2 macrophages were blocked with 2.4G2 blocking buffer for 15 min at 4°C. 
Then, cells were surface stained with fluorescently conjugated FACS antibodies including 
V450-conjugated anti-CD86, FITC-conjugated anti-MHC II, and FITC-conjugated anti-
CD206 antibodies and isotype control antibodies for 30 min at 4°C in dark condition. Cells 
were washed with 150 ul FACS buffer (1% FBS in PBS) and centrifuged at 2,000 rpm for 
2 min. After washing with FACS buffer, single cell suspensions were obtained with cell 
strainers and resuspended in FACS buffer. Then cells were run on a LSR-II Fortessa Flow 
Cytometer (BD Biosciences). Data were analyzed with FlowJo software.
Cytometric bead array
To measure the levels of M1 and M2 secrete cytokines, the mouse TNF-α, IL-6, and IL-
10 flex kits (BD Biosciences) were used. The assays were performed according to the 
manufacturer's instructions. Samples and standards were processed on the BD FACSVerse 
Flow Cytometer (BD Biosciences). Data were analyzed with FlowJo software (FlowJo, LLC, 
Ashland, OR, USA).
Immunoblot analysis
Cells were harvested and lysed in lysis buffer (1% Triton X-100 in TBS). The concentrations 
of protein were measured by bicinchoninic acid assay (Thermo Fisher Scientific, Waltham, 
MA, USA). The proteins were separated by 10% SDS-polyacrylamide gel electrophoresis 
gels and transferred to polyvinylidene difluoride membranes. The blots were blocked in 5% 
skim milk and 0.05% Tween in PBS for 1 h, incubated with primary antibodies, and probed 
with horseradish peroxidase-conjugated secondary antibodies, followed by incubation with 
enhanced chemiluminescence reagents (Thermo Fisher Scientific).
RNA extraction, cDNA preparation, and quantitative real-time PCR
Cells were harvested and total RNA were isolated using RNeasy Mini kit (Qiagen, Hilden, 
Germany). The cDNA synthesis was performed with 1 ug RNA using Prime script 1st strand 
cDNA synthesis kit according to the manufacturer's instructions (Takara Bio Inc., Kusatsu, 
Japan). The cDNA obtained from cells was quantified by quantitative real-time PCR using 
SYBR Green PCR kit (Applied Biosystems, Foster City, CA, USA). The reaction included 
95°C for 10 min, which was followed by a 3-step PCR program of 95°C for 30 s, 55 °C for 1 
min, and 72°C for 30 s repeated for 50 cycles. The PCR was performed in triplicate for each 
sample. Quantitation was performed by the comparative Ct (2−ΔΔCt) method. The Ct value for 
each sample was normalized by the value for β actin gene. Two independent experiments 
were analyzed statistically for differences in the mean values, and p values are indicated in 
the figures.
Statistical analysis
The data are presented as mean±standard error of the mean (SEM). Statistical significance 
was determined using unpaired 2-tailed Student's t-test. p<0.05 was considered significant.
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RESULTS
Viperin is basally expressed in murine bone marrow cells and BMDMs.
Viperin was identified in human primary macrophages treated with IFN-γ (8). To investigate 
the role of viperin in the macrophages, we isolated murine bone marrow cells from mice 
and assessed viperin expression in each cell population. Viperin expression was detected 
in most bone marrow cells including granulocytes (CD11bhighLy6Cmiddle, 19.1%), monocytes 
(CD11bmiddleLy6Chigh, 4.51%), and other cell populations (CD11blowLy6Clow; CD11bhighLy6Clow; 
CD11blowLy6Chigh) in the absence of IFN treatment (Fig. 1A). It has been well established that 
bone marrow cells differentiate into macrophages in M-CSF or GM-CSF conditioned media 
(20-22). Viperin expression was maintained in the BMDMs (F4/80+CD11b+) differentiated 
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Figure 1. Viperin expression in murine bone marrow cells and BMDMs. (A) The expression of viperin in bone marrow cells. The murine bone marrow cells were 
isolated from WT C57BL/6 mice. The cells were stained with fluorescently-conjugated antibodies specific to CD11b, Ly6C, and viperin and analyzed by flow cytometry. 
Cell fractions were gated in a flow cytogram. Specific cell types were confirmed by expression levels of CD11b and Ly6C (Granulocytes, CD11bhighLy6Cmiddle; Monocytes, 
CD11bmiddleLy6Chigh). Viperin expression of each cell population was shown in flow histograms. Shaded histograms represent staining with anti-viperin antibody; open 
histograms represent staining with an isotype-matched control antibody of irrelevant specificity. Data are representative of two independent experiments. (B, C) The 
expression of viperin in BMDMs. The bone marrow cells were differentiated into BMDMs by incubation in M-CSF or GM-CSF conditioned media for 7 days. The cells 
were stained with fluorescently-conjugated antibodies specific to CD11b and F4/80. Cell fractions were analyzed by flow cytometry. BMDMs specificity was confirmed 
by expression of F4/80 and CD11b (F4/80+CD11b+). BMDMs were washed and plated in 6-well plates containing media without M-CSF or GM-CSF. The cells were 
treated with or without type I IFN (1,000 U/ml) for 8 h or IFN-γ (20 ng/ml) and LPS (100 ng/ml) for 24 h. Viperin expression in BMDMs was detected by immunoblot 
using monoclonal antibody specific to viperin (MaP.VIP). β-actin served as a protein-loading control. 
BM, bone marrow cells; BM+M-CSF, BMDMs differentiated with M-CSF; BM+GM-CSF, BMDMs differentiated with GM-CSF under the indicated conditions.
with M-CSF but not with GM-CSF (Fig. 1B and C). Consistent with previous reports (8,13), 
viperin expression was significantly increased in BMDMs differentiated with M-CSF or GM-
CSF in the presence of IFN and/or LPS treatment (Fig. 1C). The results indicated that viperin 
is basally expressed in murine bone marrow cells and its expression is maintained in BMDMs 
differentiated with M-CSF.
Viperin has little effect on the phenotypes of BMDMs.
To examine the effects of viperin on expression of macrophage markers and inflammatory 
cytokines in BMDMs, we isolated bone marrow cells from WT and viperin KO mice and 
differentiated into BMDMs in GM-CSF or M-CSF conditioned media. There were little 
differences in the expression levels of iNOS, Cd80, and Cd86 known as M1 macrophage 
markers, Tnf-a, Il-1b, Il-6, Il-12, and Il-23 known as M1 macrophage cytokines, Cd163, Cd206, 
and Arg-1 known as M2 macrophage markers, and Il-10 and Tgf-b known as M2 macrophage 
cytokines between WT and viperin KO BMDMs differentiated with GM-CSF (Fig. 2A). Similar 
results were obtained from WT and viperin KO BMDMs differentiated with M-CSF, although 
the expression levels of Tnf-a and Il-23 cytokines in viperin KO BMDMs had a twofold decrease 
(Fig. 2B). The results indicated that viperin expression is not required for the phenotypes of 
BMDMs differentiated with GM-CSF or M-CSF.
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Figure 2. Viperin effects on the BMDMs differentiated with M-CSF or GM-CSF. The bone marrow cells were isolated from WT and viperin KO C57BL/6 mice and 
differentiated into BMDMs in conditioned media. (A, B) The effects of viperin on expression of macrophage markers and cytokines. The mRNA expression levels of M1 
macrophage markers and cytokines (left) and M2 macrophage markers and cytokines (right) in BMDMs differentiated with GM-CSF (A) or M-CSF (B) were measured by 
quantitative RT-PCR and normalized to β-actin mRNA. Data are presented as mean±SEM of triplicate samples and are representative of two individual experiments. 
*p<0.05.
Viperin deficiency promotes gene expression of macrophage markers and 
cytokines in the polarized M1 and M2 macrophages.
It is well known that IFN-γ, LPS, and IL-4 stimulation can differentially induce complete 
M1 and M2 polarization (23). To examine viperin effects in completely polarized M1 and M2 
macrophages, we stimulated WT and viperin KO BMDMs with IFN-γ and LPS for 24 h and 
with IL-4 for 48 h. Viperin expression was highly increased in M1 macrophages, indicating 
that viperin, an IFN-inducible protein is expressed by Toll-like receptor and IFN signaling 
pathways under IFN-γ and LPS treatments. However, viperin expression was reduced in 
M2 macrophages, suggesting that its expression is unable to be maintained by IL-4 in the 
absence of M-CSF (Fig. 3A). Polarization of BMDMs into M1 and M2 macrophages was 
assessed by measuring the expression levels of M1 and M2 markers (Fig. 3B). As expected, 
iNOS, an M1 marker was upregulated in both WT and viperin KO M1 macrophages but not 
in M2 macrophages. Arg-1, an M2 marker was upregulated in both WT and viperin KO M2 
macrophages but not in M1 macrophages as well. Interestingly, the expression levels of iNOS 
and Arg-1 in viperin KO M1 and M2 macrophages were highly increased, when compared 
to those in WT macrophages (Fig. 3B). To further analyze this phenotype, we examined 
gene expression of macrophage markers and cytokines in WT and viperin KO M1 and M2 
macrophages (Fig. 3C). The expression levels of M1 macrophage markers, iNOS, Cd80, and 
Cd86 and M1 cytokines, Tnf-a, Il-1b, Il-6, Il-12, and Il-23 in viperin KO M1 macrophages were 
significantly higher than those in WT M1 macrophages. Similar to these patterns, the 
expression levels of M2 macrophage markers, Cd163, Cd206, and Arg-1 and M2 cytokines, Il-10 
and Tgf-b in viperin KO M2 macrophages were also increased when compared to those in WT 
M2 macrophages. The results indicated that viperin deficiency promotes the phenotypes of 
M1 and M2 macrophages, suggesting that viperin expression may play a key role as a regulator 
in macrophage polarization.
It is also known that interferon regulatory factors (IRFs) have a crucial role in the 
polarization of M1 and M2 macrophages (23-25). We examined gene expression of IRFs in 
WT and viperin KO M1 and M2 macrophages (Fig. 3D). The expression levels of Irf-1, Irf-5, 
and Irf-8 known as M1-related transcriptional factors and Irf-3 and Irf-4 known as M2-related 
transcriptional factors in WT M1 and M2 macrophages were similar to those of viperin KO 
macrophages. The results indicated that IRFs are upstream molecules of viperin in the IFN 
signaling pathway.
Viperin deficiency enhances macrophage marker protein expression and 
cytokine secretion in the polarized M1 and M2 macrophages.
To confirm the effect of viperin expression on macrophage polarization, we investigated 
M1 and M2 marker protein expression on cell surface and cytokine secretion using flow 
cytometry. The expression levels of M1 marker proteins, MHC class II and CD86 and an 
M2 marker protein, CD206 in viperin KO M1 and M2 macrophages were increased, when 
compared to those in WT macrophages (Fig. 4A). Furthermore, in cytometric bead array, 
the secretion levels of M1 cytokines, TNF-α and IL-6 and an M2 cytokine, IL-10 in viperin KO 
M1 and M2 macrophages were higher than those in WT macrophages (Fig. 4B). The data 
indicated that viperin expression indeed regulates expression of macrophage markers and 
secretion of cytokines in the polarized M1 and M2 macrophages.
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DISCUSSION
Viperin is highly induced in primary human and mouse macrophages treated with 
IFN-γ and in mouse macrophages of lymphoid organs acutely infected with lymphocytic 
choriomeningitis virus (8,13,26). Our study showed that viperin is not only expressed in 
murine bone marrow cells, but also expressed in BMDMs differentiated with M-CSF in the 
absence of IFN treatment or virus infection. However, the basal expression of viperin did not 
affect the phenotypes, at least expression of macrophage markers and cytokines, between 
WT and viperin KO BMDMs. It suggested that: 1) the viperin expression level is not enough 
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Figure 4. Viperin deficiency enhances expression of macrophage marker proteins and secretion of cytokines in the polarized macrophages. (A) The effect of 
viperin on expression of M1 and M2 marker proteins on cell surface. WT and viperin KO BMDMs were polarized into M1 and M2 macrophages as described above. 
The cells were stained with fluorescently-conjugated antibodies specific to MHC II, CD86, and CD206 and analyzed by flow cytometry. Left cytograms represent 
staining with an isotype-matched control antibody of irrelevant specificity. Right fraction on each cytogram indicates cell populations expressing M1 and M2 
specific markers. MHC II and CD86, M1 markers; CD206, an M2 marker. (B) The effect of viperin on secretion of M1 and M2 cytokines. Cytometric bead array was 
performed. Open bars indicate cytokines secreted from WT M1 and M2 macrophages and closed bars represent cytokines secreted from viperin KO M1 and M2 
macrophages. TNF-α and IL-6, M1 cytokines; IL-10, an M2 cytokine. Data are presented as concentration of cytokines secreted from M1 and M2 macrophages and 
are representative of 2 individual experiments. 
FSC-H, forward scatter height.
to alter the phenotypes of BMDMs, 2) viperin requires expression of other factors to affect 
the phenotypes of BMDMs, and 3) viperin expression might be involved in other functions 
including metabolic regulation rather than in immunological phenotypes of BMDMs. 
Furthermore, we demonstrated that viperin deficiency facilitates expression of macrophage 
markers and secretion of cytokines in M1 and M2 macrophages, implying a regulatory 
role of viperin in macrophage differentiation and polarization. The data suggested that 
viperin expression determines immunological functions of the completely differentiated 
macrophages, M1 and M2 macrophages which are activated with stimuli such as IFNs and 
virus-induced inflammatory cytokines in certain environment.
The main functions of macrophages are phagocytosis, endocytosis, secretion, and microbial 
killing (27). M1 and M2 macrophages have enhanced functional capacity compared 
with undifferentiated macrophages. Viperin effects on specific functions of M1 and M2 
macrophages such as phagocytosis and endocytosis need to be further elucidated.
The role of viperin in M1 and M2 macrophages can be considered in macrophage-
associated diseases such as asthma and atherosclerosis. When macrophages are exposed 
to local microenvironments, they are recruited to the sites and polarized into M1 or M2 
phenotypes. Polarization of macrophages has been shown to have a crucial impact on asthma 
pathogenesis (28). Recent studies also showed that M2 macrophages play a central role in 
allergic asthma through their bidirectional interactions with immune cells and inflammatory 
mediators (29). In addition, it is well known that M1 macrophages are more likely to lead 
to an acute atherothrombotic vascular event (30), while M2 macrophages are associated 
with tissue repair and phagocytic capacities, enhancing plaque stability (31). A recent 
study showed that Irgm1 promotes murine M1 but not M2 macrophage polarization and its 
haplodeficiency renders ApoE KO mice resistant to atherosclerosis (32). Therefore, our data 
suggested that viperin regulation in macrophage polarization provides a potentially effective 
therapeutic strategy for macrophage-associated diseases.
Given the opposite roles of M1 and M2 macrophages in inflammatory responses and the 
effects of viperin on both of these polarized macrophages, viperin expression may act 
differently for the whole body in terms of protection or pathogenesis. Viperin expression may 
play a prophylactic role for inflammatory pathogenesis, including macrophage-associated 
diseases, by reducing the signature gene expression and cytokine production of M1 
macrophages, although its expression can reduce the protective role of M1 macrophages in 
infections. On the other hand, viperin expression in M2 macrophages may function inversely.
In conclusion, we demonstrated that viperin participates in the polarization of macrophages. 
Viperin deficiency could increase the expression of M1 and M2 macrophage markers and 
cytokines. Our findings suggest that viperin may play a critical role in differentiation of 
macrophages and determination of phenotypes of M1 and M2 macrophages and provide clues 
to macrophage-related diseases.
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